Certara to Participate in the Barclays Global Healthcare Conference

PRINCETON, N.J., Feb. 27, 2023 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in biosimulation, today announced that Company management will participate in the Barclays Global Healthcare Conference.

Company management will present at 11:15AM ET on Wednesday, March 15^th, 2023.

A live webcast of the event will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter.

About Certara
Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions and regulatory agencies across 62 countries.

Investor Relations Contact:
David Deuchler
Gilmartin Group
[email protected]

Media Contact:
Daniel Yunger
Kekst CNC
[email protected]

You May Also Be Interested In

• New Crypto Pepeto Announces Crossing 41,000 Buyers Fast as the BNB Price Prediction Targets $1,755
• Northern Discovery Metals Announces Marketing Program
• Christopher DiGirolamo Named to The Best Lawyers in America 2027 Edition for Personal Injury Litigation